报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 96.9% | 57.41% | -1.12% | 2/158 | 22.23% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 97.99% | 53.37% | -0.94% | 1/158 | 32.75% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 98.92% | 59.45% | 67.12% | 1/158 | 51.26% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 59.19% | -11.53% | -3.84% | 56/158 | 51.17% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 61.56% | -10.14% | -3.66% | 51/158 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 63.89% | -10.77% | 2.99% | 45/158 | 38.03% | 迈威生物 | 99.8% | 行业排名> |
2023-03-31 | 62.04% | 2% | -7.28% | 50/158 | 52.88% | 迈威生物 | 99.46% | 行业排名> |
2022-12-31 | 66.91% | -11.01% | -2.33% | 44/158 | 53.39% | 迈威生物 | 99.75% | 行业排名> |
2022-09-30 | 68.5% | 2% | -4.34% | 40/158 | 6.36% | 迈威生物 | 99.67% | 行业排名> |
2022-06-30 | 71.61% | -8.93% | -4.75% | 39/158 | 21.22% | 迈威生物 | 99.44% | 行业排名> |
2021-12-31 | 75.18% | -6.21% | -4.38% | 33/158 | 54.96% | 迈威生物 | 98.57% | 行业排名> |
2021-06-30 | 78.63% | 26.22% | -1.91% | 24/158 | 47.38% | 首药控股 | 99.93% | 行业排名> |
2020-12-31 | 80.16% | -0.98% | -0.98% | 22/158 | -145.98% | 艾力斯 | 99.41% | 行业排名> |
2019-12-31 | 80.95% | 2.5% | 2.5% | 17/158 | -1213.5% | 艾力斯 | 98.7% | 行业排名> |
2018-12-31 | 78.98% | 2% | 26.78% | 24/158 | -207.91% | 艾力斯 | 99.4% | 行业排名> |
2015-06-30 | 62.29% | 2% | 2% | 19/158 | 45.36% | 首药控股 | 99.94% | 行业排名> |